BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Apr 23, 2025
Product Development

Degraders, bispecifics define translational trends at AACR 

Plus: New targets involving glycosylation, angiogenesis and more
BioCentury | Nov 6, 2024
Distillery Therapeutics

Increasing UCHL1 activity for osteoarthritis

BioCentury | Feb 16, 2018
Clinical News

FDA approves Banyan's brain trauma blood test

Items per page:
1 - 5 of 5